The Effectiveness of Interventions Using Electronic Reminders to Improve Adherence to Hypertension Medication: A Systematic Review
DOI:
https://doi.org/10.61841/h3wztd18Keywords:
adherence, hypertensionAbstract
Hypertension is a global health problem and a major risk factor for cardiovascular diseases such as ischemic heart disease and stroke. Increasing the prevalence of hypertension causes morbidity and premature mortality as well as rises the burden of health costs. One of the most important treatments is adherence to medication and lifestyle modification, but those interventions need to be enhanced. The study was aimed to evaluate the effectiveness of electronic reminders to improve adherence in patients with hypertension. This systematic review used the related elements to content chosen by the PRISMA statement. Four databases were used to collect the data, SCOPUS, PUBMED, CINAHL, and MEDLINE with articles published between 2010 and 2019. Only randomized control trials (RCTs) with hypertension patients without any acute complications and healthcare professionals have been collected on this study. The intervention was an electronic reminder to evaluate adherence and quality study should have been conducted. The primary outcomes were changes in mean systolic and diastolic blood pressure values and patients’ compliance. Fourteen articles were included to assess adherence and blood pressure as outcomes. The most effective types of intervention were short message services (SMS), nurse-led email reminders, portal-based assessment, and electronic pillbox. An education session was conducted in each intervention. Medication adherence and hypertension control were improved after 24 weeks with reminders twice a day. Although different interventions had a different effect on blood pressure and adherence, overall, an SMS method can potentially improve adherence to hypertension. The majority of studies reported beneficial approaches to low cost and safety.
Downloads
References
[1] WHO, “The top 10 causes of death.” 2017.
[2] Perhimpunan Dokter Hipertensi Indonesia, “Konsensus Penatalaksanaan Hipertensi 2019,” in Indonesia Society of Hypertension, vol. 15, 2019.
[3] J. Redon, H. R. Brunner, C. Ferri, K. F. Hilgers, R. Kolloch, and G. van Montfrans, “Practical solutions to the challenges of uncontrolled hypertension: a white paper,” J. Hypertens., vol. 26, pp. S1–S14, 2008.
[4] K. A. Britton, J. M. Gaziano, and L. Djoussé, “Normal systolic blood pressure and risk of heart failure in US male physicians,” Eur. J. Heart Fail., vol. 11, no. 12, pp. 1129–1134, 2009.
[5] Kementrian Kesehatan RI, “Pusat data dan informasi hipertensi,” Jakarta Selatan Kementrian Kesehatan. Diperoleh dari www. depkes. go. id/download. php, 2014.
[6] American Heart Association, “A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,” vol. 71, no. 6, 2018, pp. E13–E115.
[7] Kemenkes RI, “Laporan Hasil Riset Kesehatan Dasar (Riskesdas) Indonesia tahun 2018,” Riset Kesehatan Dasar 2018. pp. 182–183, 2018.
[8] J. Redon, J.-J. Mourad, R. E. Schmieder, M. Volpe, and T. W. Weiss, “Why in 2016 are patients with hypertension not 100% controlled? A call to action,” J. Hypertens., no. 34, pp. 1480–1488, 2016.
[9] P. H. P. Márquez et al., “Potentially inappropriate antihypertensive prescriptions to elderly patients: results of a prospective, observational study,” Drugs Aging, vol. 34, no. 6, pp. 453–466, 2017.
[10] B. Williams et al., “Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for,” J Hypertens, vol. 36, no. 10, pp. 1953–2041, 2018.
[11] N. R. Poulter et al., “Medication adherence in hypertension,” J. Hypertens., vol. 38, no. 4, pp. 579–587, 2020.
[12] M. N. Hill, N. H. Miller, S. DeGeest, and A. S. of H. W. Group, “Adherence and persistence with taking medication to control high blood pressure,” J. Am. Soc. Hypertens., vol. 5, no. 1, pp. 56–63, 2011.
[13] M. T. Brown and J. K. Bussell, “Medication adherence: WHO cares?,” in Mayo clinic proceedings, 2011, vol. 86, no. 4, pp. 304–314.
[14] B. Vrijens, G. Vincze, P. Kristanto, J. Urquhart, and M. Burnier, “Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories,” Bmj, vol. 336, no. 7653, pp. 1114–1117, 2008.
[15] T. J. Bramley, B. S. Nightengale, F. Frech-Tamas, and P. P. Gerbino, “Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations,” J. Manag. Care Pharm., vol. 12, no. 3, pp. 239–245, 2006.
[16] G. Corrao et al., “Better compliance to antihypertensive medications reduces cardiovascular risk,” J. Hypertens., vol. 29, no. 3, pp. 610–618, 2011.
[17] R. Nieuwlaat et al., “Interventions for enhancing medication adherence,” Cochrane database Syst. Rev., no. 11, 2014.
[18] S. Agarwal et al., “Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist,” bmj, vol. 352, p. i1174, 2016.
[19] M. Tomlinson, M. J. Rotheram-Borus, L. Swartz, and A. C. Tsai, “Scaling up mHealth: where is the evidence?,” PLoS Med., vol. 10, no. 2, 2013.
[20] D. Zurovac, A. O. Talisuna, and R. W. Snow, “Mobile phone text messaging: tool for malaria control in Africa,” PLoS Med., vol. 9, no. 2, 2012.
[21] J. E. Winland-Brown and J. Valiante, “Effectiveness of different medication management approaches on elders’ medication adherence.,” Outcomes Manag. Nurs. Pract., 2000.
[22] K. C. Buckwalter, B. J. Wakefield, B. Hanna, and J. Lehmann, “New technology for medication adherence: electronically managed medication dispensing system.,” J. Gerontol. Nurs., 2004.
[23] R. Suzuki and T. Hasegawa, “Evaluation of a one-dose package medication support system for community-based elderly patients and eldercare facilities,” Am. J. Heal. Pharm., 2018.
[24] K. D. Marek et al., “Nurse care coordination and technology effects on health status of frail older adults via enhanced self-management of medication: Randomized clinical trial to test efficacy,” Nurs. Res., 2013.
[25] A. Liberati et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.,” BMJ, vol. 339, 2009.
[26] J. P. T. Higgins et al., “The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials,”
Bmj, vol. 343, p. d5928, 2011.
[27] A. Christensen et al., “The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: A randomized controlled trial,” J. Hypertens., vol. 28, no. 1, pp. 194–200, 2010.
[28] G. Cicolini et al., “Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: A randomized controlled trial,” Int. J. Nurs. Stud., vol. 51, no. 6, pp. 833–843, 2014.
[29] K. Bobrow et al., “Efficacy of a text messaging (SMS) based intervention for adults with hypertension: Protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial,” BMC Public Health, vol. 14, no. 1, pp. 1–9, 2014.
[30] A. Schoenthaler et al., “A practice-based randomized controlled trial to improve medication adherence among Latinos with hypertension: study protocol for a randomized controlled trial,” Trials, vol. 16, no. 1, pp. 1–11, 2015.
[31] I. M. Kronish et al., “An Electronic Adherence Measurement Intervention to Reduce Clinical Inertia in the Treatment of Uncontrolled Hypertension: The MATCH Cluster Randomized Clinical Trial,” J. Gen.
Intern. Med., vol. 31, no. 11, pp. 1294–1300, 2016.
[32] M. Ashoorkhani et al., “Comparing the effectiveness of the BPMAP (Blood Pressure Management Application) and usual care in self-management of primary hypertension and adherence to treatment in patients aged 30-60 years: Study protocol for a randomized controlled trial,” Trials, vol. 17, no. 1, pp. 1– 8, 2016.
[33] M. H. Maslakpak and M. Safaie, “A comparison between the effectiveness of short message service and reminder cards regarding medication adherence in patients with hypertension: A randomized controlled clinical trial,” Int. J. Community Based Nurs. Midwifery, vol. 4, no. 3, pp. 209–218, 2016.
[34] D. Jha et al., “Protocol for the mWellcare trial: A multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual car,” BMJ Open, vol. 7, no. 8, 2017.
[35] S. C. Bailey et al., “Development and rationale for a multifactorial, randomized controlled trial to test strategies to promote adherence to complex drug regimens among older adults,” Contemp. Clin. Trials, vol. 62, pp. 21–26, 2017.
[36] L. Xu, W. Y. Fang, F. Zhu, H. G. Zhang, and K. Liu, “A coordinated PCP-Cardiologist Telemedicine Model (PCTM) in China’s community hypertension care: Study protocol for a randomized controlled trial,” Trials, vol. 18, no. 1, pp. 1–10, 2017.
[37] Z. Haramiova, M. Stasko, M. Hulin, T. Tesar, M. Kuzelova, and D. M. Morisky, “The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients’ adherence to antihypertensive medication (SPPA): Study protocol for a randomized controlled trial,” Trials, vol. 18, no. 1, pp. 1–15, 2017.
[38] P. Varleta et al., “Mobile phone text messaging improves antihypertensive drug adherence in the community,” J. Clin. Hypertens., vol. 19, no. 12, pp. 1276–1284, 2017.
[39] P. Zhai et al., “The impact of short message services and personal consultation by pharmacy students on medication adherence and blood pressure control: Study protocol for a cluster randomized trial,” Patient Prefer. Adherence, vol. 13, pp. 627–636, 2019.
[40] J. Chandler, L. Sox, K. Kellam, L. Feder, L. Nemeth, and F. Treiber, “Impact of a culturally tailored mhealth medication regimen self-management program upon blood pressure among hypertensive hispanic adults,” Int. J. Environ. Res. Public Health, vol. 16, no. 7, pp. 1–13, 2019.
[41] World Health Organzization, “Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003 [cited 2018 Jun 2].” .
[42] N. Tran, J. M. Coffman, K. Sumino, and M. D. Cabana, “Patient reminder systems and asthma medication adherence: a systematic review,” J. Asthma, vol. 51, no. 5, pp. 536–543, 2014.
[43] B. S. Fjeldsoe, A. L. Marshall, and Y. D. Miller, “Behavior change interventions delivered by mobile telephone short-message service,” Am. J. Prev. Med., vol. 36, no. 2, pp. 165–173, 2009.
[44] C. Free et al., “Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single- blind, randomised trial,” Lancet, vol. 378, no. 9785, pp. 49–55, 2011.
[45] I. Haapala, N. C. Barengo, S. Biggs, L. Surakka, and P. Manninen, “Weight loss by mobile phone: a 1- year effectiveness study,” Public Health Nutr., vol. 12, no. 12, pp. 2382–2391, 2009.
[46] R. Whittaker, H. McRobbie, C. Bullen, A. Rodgers, and Y. Gu, “Mobile phone‐based interventions for smoking cessation,” Cochrane Database Syst. Rev., no. 4, 2016.
[47] W. M. Vollmer et al., “Improving adherence to cardiovascular disease medications with information technology,” Am. J. Manag. Care, vol. 20, no. 17, pp. SP502–SP510, 2014.
[48] L. J. Anderson et al., “A systematic overview of systematic reviews evaluating medication adherence interventions,” Am. J. Heal. Pharm., vol. 77, no. 2, pp. 138–147, 2020.
[49] R. H. Chapman, S. L. Kowal, S. B. Cherry, C. P. Ferrufino, C. S. Roberts, and L. Chen, “The Modeled Lifetime Cost‐Effectiveness of Published Adherence‐Improving Interventions for Antihypertensive and Lipid‐Lowering Medications,” Value Heal., vol. 13, no. 6, pp. 685–694, 2010.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
